AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor-Reference-Cited by-同舟云学术

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

Published:1998-01 Issue:1 Volume:4 Page:72-77
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Donzella George A.,Schols Dominique,Lin Steven W.,Esté José A.,Nagashima Kirsten A.,Maddon Paul J.,Allaway Graham P.,Sakmar Thomas P.,Henson Geoffrey,DeClercq Erik,Moore John P.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm0198-072.pdf

Reference49 articles.

1. Feng, Y., Broder, C.C., Kennedy, P.E. & Berger, E.A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane G protein coupled receptor. Science 272, 872–877 (1996).

2. Bleul, C.C., et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829–833 (1996).

3. Oberlin, E., et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833–835 (1996).

4. Premack, B.A. & Schall, T.J. Chemokine receptors: Gateways to inflammation and infection. Nature Med. 2, 1174–1178 (1996).

5. Richman, D.D. & Bozzette, S.A. The impact of the syncytium inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169, 968–974 (1994).

Cited by 711 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatty acid conjugated EPI-X4 derivatives with increased activity and in vivo stability;Journal of Controlled Release;2024-09

2. Applying Molecular Modeling to the Design of Innovative, Non-Symmetrical CXCR4 Inhibitors with Potent Anticancer Activity;International Journal of Molecular Sciences;2024-08-30

3. Potentiating effect of AMD3100 on bone morphogenetic protein-2 induced bone regeneration;Maxillofacial Plastic and Reconstructive Surgery;2024-06-17

4. Clostridioides difficile toxin B subverts germinal center and antibody recall responses by stimulating a drug-treatable CXCR4-dependent mechanism;Cell Reports;2024-05

5. A scientific career from the early 1960s till 2023: A tale of the various protagonists;Biochemical Pharmacology;2024-05